Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Heimesaat, Markus M ^a   Dunay, Ildiko R ^b   Alutis, Marie ^a   Fischer, André ^a   Möhle, Luisa ^b   Göbel, Ulf B ^a   Kühl, Anja A ^a   Bereswill, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GAMMA INTERFERON; MESSENGER RNA; RNA 16S; TUMOR NECROSIS FACTOR ALPHA; CARD15 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; COMMENSAL; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; GENE EXPRESSION; GENOTYPE; ILEITIS; INTESTINE FLORA; KIDNEY; LIVER; MACROPHAGE; MICROGLIA; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE LOAD; RNA ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BRAIN; C57BL MOUSE; FEMALE; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PARASITOLOGY; PATHOGENICITY; SMALL INTESTINE; TOXOPLASMA;

ANIMALS; BACTERIAL TRANSLOCATION; BRAIN; FEMALE; GASTROINTESTINAL MICROBIOME; ILEITIS; INFLAMMATION; INTERFERON-GAMMA; INTESTINE, SMALL; MICE; MICE, INBRED C57BL; NOD2 SIGNALING ADAPTOR PROTEIN; PARASITE LOAD; RNA, RIBOSOMAL, 16S; TOXOPLASMA; TOXOPLASMOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939861552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105120     Document Type: Article

References (55)

1. Munoz M, Liesenfeld O, Heimesaat MM (2011) Immunology of Toxoplasma gondii. Immunol Rev 240: 269-285.
2. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, et al. (2008) Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29: 306-317.
3. Dunay IR, Chan WC, Haynes RK, Sibley LD (2009) Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob Agents Chemother 53: 4450-4456.
4. Mohle L, Parlog A, Pahnke J, Dunay IR (2014) Spinal cord pathology in chronic experimental Toxoplasma gondii infection. Eur J Microbiol Immunol (Bp) 4: 65-75.
5. Parlog A, Harsan LA, Zagrebelsky M, Weller M, von Elverfeldt D, et al. (2014) Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech 7: 459-469.
6. McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, et al. (1989) Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J Immunol 142: 3247-3255. (Pubitemid 19129950)
7. McLeod R, Skamene E, Brown CR, Eisenhauer PB, Mack DG (1989) Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J Immunol 143: 3031-3034. (Pubitemid 19281856)
8. Liesenfeld O, Kosek J, Remington JS, Suzuki Y (1996) Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184: 597-607. (Pubitemid 26324113)
9. Jankovic D, Kugler DG, Sher A (2010) IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol 3: 239-246.
10. Liesenfeld O (2002) Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185 Suppl 1: S96-101.
11. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, et al. (2006) Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 177: 8785-8795. (Pubitemid 44893845)
12. Erridge C, Duncan SH, Bereswill S, Heimesaat MM (2010) The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 5: e9125.
13. Shaw MH, Reimer T, Kim YG, Nunez G (2008) NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 20: 377-382.
14. Tada H, Aiba S, Shibata K, Ohteki T, Takada H (2005) Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 73: 7967-7976. (Pubitemid 41740282)
15. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, et al. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276: 4812-4818.
16. Ogura Y, Lala S, Xin W, Smith E, Dowds TA, et al. (2003) Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52: 1591-1597. (Pubitemid 37363443)
17. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, et al. (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993-1000. (Pubitemid 36389802)
18. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, et al. (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277: 41701-41705. (Pubitemid 35257477)
19. Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, et al. (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 278: 41702-41708. (Pubitemid 37310428)
20. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872. (Pubitemid 36800360)
21. Grimes CL, Ariyananda Lde Z, Melnyk JE, O'Shea EK (2012) The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J Am Chem Soc 134: 13535-13537.
22. Moreira LO, Zamboni DS NOD1 and NOD2 (2012) Signaling in Infection and Inflammation. Front Immunol 3: 328.
23. Caetano BC, Biswas A, Lima DS, Jr., Benevides L, Mineo TW, et al. (2011) Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii. Eur J Immunol 41: 3627-3631.
24. Shaw MH, Reimer T, Sanchez-Valdepenas C, Warner N, Kim YG, et al. (2009) T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat Immunol 10: 1267-1274.
25. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, et al. (2011) Novel murine infection models provide deep insights into the "menage a trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 6: e20953.
26. Haag LM, Fischer A, Otto B, Plickert R, Kuhl AA, et al. (2012) Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. PLoS One 7: e40761.
27. Biswas A, Petnicki-Ocwieja T, Kobayashi KS (2012) Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med (Berl) 90: 15-24.
28. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734. (Pubitemid 40194644)
29. Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ (2012) Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol 24: 398-404.
30. Koppe U, Suttorp N, Opitz B (2012) Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 14: 460-466.
31. Benson A, Pifer R, Behrendt CL, Hooper LV, Yarovinsky F (2009) Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe 6: 187-196.
32. Sydora BC, Macfarlane SM, Walker JW, Dmytrash AL, Churchill TA, et al. (2007) Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse. Inflamm Bowel Dis 13: 947-954. (Pubitemid 47309965)
33. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, et al. (2011) Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9: 390-403.
34. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
35. Sartor RB (2010) Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology 139: 1816-1819.
36. Deloris Alexander A, Orcutt RP, Henry JC, Baker J, Jr., Bissahoyo AC, et al. (2006) Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment. Mamm Genome 17: 1093-1104. (Pubitemid 44764287)
37. Ge Z, Feng Y, Taylor NS, Ohtani M, Polz MF, et al. (2006) Colonization dynamics of altered Schaedler flora is influenced by gender, aging, and Helicobacter hepaticus infection in the intestines of Swiss Webster mice. Appl Environ Microbiol 72: 5100-5103. (Pubitemid 44078848)
38. Heimesaat MM, Dunay IR, Fuchs D, Trautmann D, Fischer A, et al. (2011) The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Eur J Microbiol Immunol (Bp) 1: 302-310.
39. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, et al. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A 106: 15813-15818.
40. Geddes K, Rubino S, Streutker C, Cho JH, Magalhaes JG, et al. (2010) Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect Immun 78: 5107-5115.
41. Coudeyras S, Forestier C (2010) [Microbiota and probiotics: effects on human health]. Can J Microbiol 56: 611-650.
42. O'Mahony D, Murphy S, Boileau T, Park J, O'Brien F, et al. (2010) Bifidobacterium animalis AHC7 protects against pathogen-induced NF-kappaB activation in vivo. BMC Immunol 11: 63.
43. Dunay IR, Heimesaat MM, Bushrab FN, Muller RH, Stocker H, et al. (2004) Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother 48: 4848-4854. (Pubitemid 39577693)
44. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, et al. (2007) Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941-948. (Pubitemid 46999077)
45. Struck D, Frank I, Enders S, Steinhoff U, Schmidt C, et al. (2012) Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18. Eur J Microbiol Immunol (Bp) 2: 249-257.
46. Heimesaat MM, Plickert R, Fischer A, Gobel UB, Bereswill S (2013) Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni? Eur J Microbiol Immunol (Bp) 3: 36-43.
47. Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, et al. (2010) MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59: 1079-1087.
48. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, et al. (2011) Novel Murine Infection Models Provide Deep Insights into the "Menage a Trois" of Campylobacter jejuni, Microbiota and Host Innate Immunity. PLoS One 6: e20953.
49. Haag LM, Fischer A, Otto B, Plickert R, Kuhl AA, et al. (2012) Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One 7: e35988.
50. Heimesaat MM, Haag LM, Fischer A, Otto B, Kuhl AA, et al. (2013) Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Eur J Microbiol Immunol (Bp) 3: 174-182.
51. Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, et al. (2009) Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 206: 3047-3059.
52. Rausch S, Held J, Fischer A, Heimesaat MM, Kuhl AA, et al. (2013) Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. PLoS One 8: e74026.
53. Heimesaat MM, Boelke S, Fischer A, Haag LM, Loddenkemper C, et al. (2012) Comprehensive postmortem analyses of intestinal microbiota changes and bacterial translocation in human flora associated mice. PLoS One 7: e40758.
54. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74. (Pubitemid 40984624)
55. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, et al. (2011) Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog 7: e1002236.